Phospho-HCK (Tyr521) Antibody

What is the exact epitope specificity of Phospho-HCK (Tyr521) antibodies?

Phospho-HCK (Tyr521) antibodies are designed to detect endogenous levels of Hck protein exclusively when phosphorylated at tyrosine 521 . The antibodies are typically produced against synthesized phosphopeptides derived from the region surrounding the Tyr521 phosphorylation site of human Hck . The specific epitope sequence generally includes E-S-Q(p)-Y-Q, with the phosphorylated tyrosine being the critical recognition element . This high specificity allows researchers to monitor the phosphorylation state of this regulatory site without cross-reactivity to non-phosphorylated forms.

How does nomenclature variation affect antibody selection for Hck phosphorylation research?

When working with Phospho-HCK antibodies, researchers should be aware of important nomenclature variations:

These variations reflect different reference sequences or isoform-specific numbering systems. When selecting an antibody, researchers should verify the exact position being targeted by cross-referencing with UniProt accession numbers (P08631 for human Hck) and consulting the specific epitope information provided by manufacturers .

What are the optimal dilution ratios for different experimental applications of Phospho-HCK (Tyr521) antibodies?

The optimal working dilutions vary by application and specific antibody formulation:

When using these antibodies for the first time in a particular experimental system, it is advisable to perform a dilution series to determine the optimal concentration for your specific sample type and detection method . The concentration of most commercial preparations is 1 mg/ml, which should be considered when calculating working dilutions .

How should researchers validate the specificity of Phospho-HCK (Tyr521) antibody in their experimental system?

Methodical validation should include:

• Positive and negative controls:

  • Positive control: Lysates from cells treated with pervanadate or other phosphatase inhibitors to increase tyrosine phosphorylation

  • Negative control: Samples treated with lambda phosphatase to remove phosphate groups

• Peptide competition assay: Pre-incubating the antibody with phospho-peptide versus non-phospho-peptide should abolish signal only with the phospho-peptide .

• Knock-out/knock-down validation: Testing reactivity in HCK-deficient samples to confirm absence of non-specific binding .

• Cross-validation with another antibody: Compare results with a different antibody targeting the same phosphorylation site but recognizing a different epitope .

• Mutagenesis studies: Compare wild-type Hck to Y521F/Y521A mutants to confirm phosphosite specificity .

These validation steps are crucial as research has shown that phospho-specific antibodies can sometimes cross-react with other phosphorylated proteins, particularly when multiple post-translational modifications occur in proximity to each other .

What storage and handling procedures maximize the stability and performance of Phospho-HCK (Tyr521) antibodies?

For optimal performance of Phospho-HCK (Tyr521) antibodies, follow these evidence-based practices:

• Storage temperature: Store at -20°C for long-term storage (up to 1 year under proper conditions) .

• Aliquoting: Upon receipt, prepare small single-use aliquots to minimize freeze-thaw cycles .

• Working stock handling: During experiments, keep antibodies on ice and return to -20°C promptly after use .

• Freeze-thaw cycles: Minimize repeated freeze-thaw cycles as they can lead to antibody denaturation and loss of activity .

• Buffer composition: Most commercial preparations contain stabilizers (50% glycerol, 0.5% BSA) and preservatives (0.02% sodium azide) - do not dilute the stock solution unless immediately using .

Research indicates that antibody activity can decrease by approximately 10-15% with each freeze-thaw cycle, so proper aliquoting is essential for maintaining consistent experimental results across studies .

Sources of False Positives:

• Cross-reactivity with similar phosphotyrosine motifs: The phospho-epitope may be present in other Src family kinases with similar sequences .

• Dephosphorylation during sample preparation: Inadequate phosphatase inhibition can lead to dephosphorylation and loss of signal .

• Secondary antibody cross-reactivity: Non-specific binding of secondary antibodies can produce bands that might be misinterpreted .

• Neighboring post-translational modifications: The presence of other modifications near Tyr521 can influence antibody recognition and specificity .

Sources of False Negatives:

• Insufficient sample amount: Phosphorylated proteins often represent a small fraction of the total protein pool .

• Epitope masking: Protein-protein interactions or additional PTMs may block antibody access to the phosphorylated residue .

• Improper transfer conditions: High molecular weight proteins or heavily phosphorylated proteins may transfer inefficiently to membranes .

• Suboptimal blocking conditions: Over-blocking can reduce antibody binding to true targets .

To minimize these issues, researchers should include appropriate controls and optimize each step of their Western blot protocol specifically for detecting phosphorylated proteins .

How does phosphorylation at Tyr521 affect HCK function in different hematopoietic cell types?

Phosphorylation at Tyr521 (also referred to as Tyr522 or Tyr527 in some nomenclatures) plays a critical regulatory role in Hck function:

• Inhibitory regulation: When phosphorylated, Tyr521 participates in an inhibitory intramolecular interaction with the SH2 domain of Hck, maintaining the kinase in an inactive conformation .

• Cell-type specific effects:

  • In monocytes and macrophages: Regulation of Tyr521 phosphorylation affects phagocytosis and respiratory burst activation through Fc receptor coupling .

  • In neutrophils: Phosphorylation state influences neutrophil migration and degranulation processes .

  • In B-lymphoid cells: Affects B cell receptor signaling and downstream immune responses .

• Subcellular localization: The phosphorylation state of Tyr521 influences protein-protein interactions and subcellular distribution of Hck isoforms . Different isoforms show distinct localization patterns:

  • Isoform 1: Lysosome, membrane, podosome membrane, and cytoplasm

  • Isoform 2: Cell membrane, caveolae, focal adhesions, cytoskeleton, and various other cellular compartments

Understanding this phosphorylation site is particularly relevant for research on hematopoietic cell function, immune responses, and potential therapeutic targeting in leukemias and inflammatory disorders .

What are the methodological considerations for studying the interplay between Tyr521 phosphorylation and other regulatory sites on HCK?

Studies investigating the complex regulatory network of Hck phosphorylation should consider:

• Multiple phosphorylation site analysis: Hck contains multiple regulatory phosphorylation sites, including the activating autophosphorylation site at Tyr416 (activation loop) that works in opposition to the inhibitory Tyr521 site . Researchers should employ methodologies that can monitor both sites simultaneously:

  • Parallel Western blots with site-specific antibodies

  • Mass spectrometry-based phosphoproteomic approaches

  • Proximity ligation assays to detect conformational changes

• SH2/SH3 domain interactions: The inhibitory effect of Tyr521 phosphorylation involves intramolecular interactions with the SH2 domain. Studies show that disrupting SH3 domain interactions (e.g., by SH3 ligands like Nef) can override the inhibitory effect of Tyr521 phosphorylation . Researchers should design experiments to assess:

  • Protein-protein interactions using co-immunoprecipitation

  • Conformational changes using FRET-based approaches

  • Functional enzyme assays to correlate phosphorylation state with kinase activity

• Mutation-based strategies: Research has shown that mutating Tyr416 to alanine results in altered catalytic properties (higher Km for peptide substrates and lower Vmax) . Similar mutation-based approaches for Tyr521 can help dissect its specific contributions.

• Activation loop and C-terminal tail cross-talk: Evidence indicates communication between the activation loop and the intramolecular binding of the SH2 and SH3 domains . Experimental designs should account for these allosteric effects when interpreting results.

How can Phospho-HCK (Tyr521) antibodies be used to investigate HCK activation in immune cell signaling pathways?

Phospho-HCK (Tyr521) antibodies provide valuable tools for dissecting immune cell signaling pathways through these methodological approaches:

• Temporal signaling dynamics: Monitor time-dependent changes in Tyr521 phosphorylation following immune receptor engagement:

  • Fc receptor activation in neutrophils and macrophages

  • B cell receptor signaling

  • Cytokine receptor stimulation (IFNG, IL2, IL6, IL8)

• Spatial organization of signaling complexes: Combine with subcellular fractionation or imaging techniques:

  • Immunofluorescence microscopy with phospho-specific antibodies

  • Proximity ligation assays to detect interactions with binding partners

  • Biochemical fractionation followed by Western blotting

• Downstream effector analysis: Correlate Tyr521 phosphorylation status with:

  • Phosphorylation of known Hck substrates (ADAM15, BCR, ELMO1, FCGR2A, GAB1, GAB2, RAPGEF1, STAT5B, TP73, VAV1 and WAS)

  • Functional outcomes (respiratory burst, phagocytosis, degranulation)

  • Cytoskeletal reorganization and cell migration

• Pharmacological intervention: Use in conjunction with:

  • Src family kinase inhibitors to establish inhibition profiles

  • Phosphatase inhibitors to stabilize phosphorylation states

  • Receptor-specific activators or blockers to establish pathway specificity

The typical experimental workflow would involve stimulation of appropriate immune cells, collection of samples at defined timepoints, and analysis using Western blotting with the phospho-specific antibody at dilutions of 1:500-1:1000 .

What approaches can be used to quantitatively measure the ratio of phosphorylated to non-phosphorylated HCK in complex biological samples?

For accurate quantification of phosphorylated versus non-phosphorylated Hck, researchers should consider these methodological approaches:

• Dual antibody detection systems:

  • Western blot with parallel detection of total Hck and phospho-Hck (Tyr521)

  • Calculation of phospho/total ratios using densitometry

  • Normalization to appropriate loading controls

• Mass spectrometry-based approaches:

  • Selected Reaction Monitoring (SRM) or Parallel Reaction Monitoring (PRM)

  • Absolute quantification using isotopically labeled peptide standards

  • Phosphoproteomic enrichment techniques to enhance detection sensitivity

• ELISA-based quantification:

  • Sandwich ELISA with capture antibodies for total Hck and detection antibodies specific for phospho-Tyr521

  • Standard curves using recombinant phosphorylated and non-phosphorylated controls

  • Optimized dilution of 1:10000 for phospho-specific antibodies in ELISA format

• Flow cytometry for single-cell analysis:

  • Permeabilization and fixation protocols optimized for phospho-epitope preservation

  • Dual staining with total Hck and phospho-Hck antibodies

  • Controls for antibody specificity validation

When designing quantitative experiments, researchers should be aware that the phosphorylation status can change rapidly during sample processing. Including phosphatase inhibitors throughout all steps is critical for maintaining the in vivo phosphorylation state . Additionally, the stoichiometry of phosphorylation at Tyr521 may vary considerably between different cell types and activation states, requiring careful experimental design and appropriate controls .